The invention discloses a detection kit used for detecting CXCR4 < + > CD8 < + > T cells and used for predicting tumor
immunotherapy, a prediction biomarker is expression
chemokine receptor 4 (CXCR4) on the CD8 < + > T cells, and the prediction biomarker is expression
chemokine receptor 4 (CXCR4) on the CD8 < + > T cells. Researches find that the expression level of CXCR4 < + > CD8 < + > T cells in tumors is related to the clinical
immunotherapy reaction effect. The application comprises the steps that the expression change level of CXCR4 + CD8 + T cells in
tumor tissue of a patient before tumor
immunotherapy is detected and analyzed through the kit, the patient is divided into a high expression group and a low expression group according to the relative expression quantity of CXCR4
protein and CD8
protein, the low expression group is poor in immunotherapy effect, and the patient is low in immunotherapy reaction; the high expression group is an immunotherapy sensitive patient; the total survival time and the progression-free survival time of a high-expression group after immunotherapy are longer than those of a low-expression group, and the method has important
clinical value in the aspects of promoting precise treatment of tumor patients and improving prognosis.